Myopia control in Mendelian forms of myopia.

ABSTRACT:

Purpose

To study the effectiveness of high-dose atropine for reducing eye growth in Mendelian myopia in children and mice.

Methods

We studied the effect of high-dose atropine in children with progressive myopia with and without a monogenetic cause. Children were matched for age and axial length (AL) in their first year of treatment. We considered annual AL progression rate as the outcome and compared rates with percentile charts of an untreated general population. We treated C57BL/6J mice featuring the myopic phenotype of Donnai-Barrow syndrome by selective inactivation of Lrp2 knock out (KO) and control mice (CTRL) daily with 1% atropine in the left eye and saline in the right eye, from postnatal days 30-56. Ocular biometry was measured using spectral-domain optical coheren

SUBMITTER: van der Sande E 

PROVIDER: S-EPMC12852259 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature